Okamoto T, et al. - Researchers gauged the association between the Geriatric Nutritional Risk Index (GNRI) and prognosis of patients with metastatic hormone-naïve prostate cancer (mHNPC). They also designed the optimal risk score predicting for prognosis. The data from the Michinoku Japan Urological Cancer Study Group database, containing information about 656 patients with mHNPC who initially received androgen-deprivation therapy between 2005 and 2017 was retrospectively reviewed. Findings suggested the probability of the poor nutrition to predict mortality in patients with mHNPC. They noted the probable utility of the risk factors, such as nutritional status and laboratory parameters in decision-making regarding aggressive treatments for patients with mHNPC.